Continuous dopaminergic stimulation for Parkinson's disease: facts and fancy

Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents·2026

Polymeric nanoparticle platforms for ibrutinib delivery: tackling solubility, CYP3A4-mediated metabolism, and resistance to facilitate BTK-targeted therapy in solid tumours.

Therapeutic delivery·2026

Propofol for depression: mechanisms and therapeutic potential.

Frontiers in physiology·2026

Related Experiment Videos

Continuous dopaminergic stimulation for Parkinson's disease: facts and fancy

Related Concept Videos

Impact of a perioperative protocol for Parkinson's disease patients on use of contraindicated drugs.

Differential pathological dynamics triggered by distinct Parkinson patient-derived α-synuclein extracts in nonhuman primates.

Nigrostriatal iron accumulation in the progression of Parkinson's disease.

Microvascular decompression for trigeminal neuralgia: A retrospective analysis of long-term outcomes and prognostic factors.

Dopaminergic denervation and associated MRI microstructural changes in the nigrostriatal projection in early Parkinson's disease patients.

Spanish expert consensus on the use of safinamide in Parkinson's disease.

The origins of the fight against rabies: a journey between the history of neuroscience and university museum collections.

Are paediatric headaches in the emergency department increasing? An Italian experience.

Neurophysiological changes after cognitive-motor tasks in Parkinson's disease patients with deep brain stimulation.

Acute ischemic stroke management in Lebanon: obstacles and solutions.

Does a single bout of exercise impacts BDNF, oxidative stress and epigenetic markers in spinal cord injury patients?

Effects of Constraint-Induced Movement Therapy on upper limb activity according to a bi-dimensional kinematic analysis in progressive multiple sclerosis patients: a randomized single-blind pilot study.

Medicaid payment policies for methadone maintenance treatment for opioid use disorder, 2020-2025.

Advanced drug delivery systems for topical treatment of common skin diseases: a decade in review.

Radiolabeled drug-delivery and controlled-release nanocarriers for arthritis: Clinical evidence, kinetic modeling, radiation-safety challenges, and precision nanotheranostics.

Centanafadine (Simtriyo®): a first-in-class triple reuptake inhibitor approved for attention-deficit/hyperactivity disorder (ADHD).

Polymeric nanoparticle platforms for ibrutinib delivery: tackling solubility, CYP3A4-mediated metabolism, and resistance to facilitate BTK-targeted therapy in solid tumours.

Propofol for depression: mechanisms and therapeutic potential.

Related Experiment Videos

Continuous dopaminergic stimulation for Parkinson's disease: facts and fancy

Related Concept Videos

Related Articles